Cassoux Nathalie, Malaise Denis, Lumbroso-Le-Rouic Livia, Le Gall Jessica, Golmard Lisa, Cardoen Liesbeth, Freneaux Paul, Bouchoucha Yassine, Aerts Isabelle, Doz François, Matet Alexandre
Department of Ocular Oncology, Institut Curie, Paris, France.
Faculté de Médecine, Université Paris Cité, Paris, France.
Ocul Oncol Pathol. 2023 Sep;9(3-4):96-100. doi: 10.1159/000531233. Epub 2023 Jun 16.
The aim of the study was to describe the successful conservative management of diffuse infiltrating retinoblastoma (DIR). Identification of pathogenic variant was done after cell-free DNA (cfDNA) analysis in aqueous humor.
Herein, we report 2 patients with unilateral, non-familial DIR with anterior and posterior involvement. Both patients underwent liquid biopsy for tumor cfDNA analysis in aqueous humor. Treatment consisted of a combination of systemic and intra-arterial chemotherapy, with consecutive intracameral and intravitreal injections of melphalan. One patient also required iodine-125 brachytherapy. In both cases, tumor cfDNA analysis revealed biallelic somatic alterations of the gene. These alterations were not found in germline DNA. Both patients retained their eyes and had a useful vision after a follow-up of 2 years.
In selected cases, conservative management of DIR is safe and effective. Tumor cfDNA analysis in aqueous humor is an effective technique to disclose somatic alterations that guide the germline molecular explorations and improve genetic counseling after conservative treatment.
本研究的目的是描述弥漫性浸润性视网膜母细胞瘤(DIR)成功的保守治疗。在房水的游离DNA(cfDNA)分析后确定致病变异。
在此,我们报告2例单侧、非家族性DIR患者,肿瘤累及前后部。两名患者均接受了房水肿瘤cfDNA分析的液体活检。治疗包括全身化疗和动脉内化疗联合,连续进行美法仑前房内和玻璃体内注射。一名患者还需要碘-125近距离放射治疗。在这两个病例中,肿瘤cfDNA分析均显示该基因的双等位基因体细胞改变。这些改变在生殖系DNA中未发现。两名患者均保留了眼球,随访2年后视力良好。
在选定的病例中,DIR的保守治疗是安全有效的。房水肿瘤cfDNA分析是一种有效的技术,可揭示体细胞改变,指导生殖系分子探索并改善保守治疗后的遗传咨询。